Infusing hospitalized Covid-19 patients with blood plasma from people who recovered from the disease had no effect on whether patients got sicker or died, according to the first completed randomized trial of the treatments.

BREAKING: Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize debate

Infusing hospitalized Covid-19 patients with blood plasma from people who recovered from the disease had no effect on whether patients got sicker or died, according to the first completed randomized trial of the treatments.

Blood plasma showed no benefit in #Covid19 patients in trial — a finding that could re-energize debate over its usefulness statnews.com/2020/10/22/blo… via @statnews

Agree with @llborio: "“We should not be using convalescent plasma. It has not been shown to help patients.” statnews.com/2020/10/22/blo… @statnews @damiangarde @matthewherper

Blood plasma showed no benefit in Covid-19 patients in trial. @damiangarde and I look into the results on a treatment that we still have not adequately studied.

Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize... statnews.com/2020/10/22/blo… via @statnews

RCT of plasma in India shows no benefit. Definitely not the last word on plasma. But again brings to fore the super high 28 day mortality rate in Recovery trial of mid 20%. In this trial, 15%. In solidarity, 12%. in ACTT, 15%. Why so high in RECOVERY?

Just last week, there was a trial testing CP and it showed no benefit.

Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize the debate statnews.com/2020/10/22/blo… via @damiangarde & @matthewherper